Guo Y - Search Results

1

Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.

Guo Y, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY. Guo Y, et al. Int J Cardiol. 2013 Oct 12;168(5):4678-84. doi: 10.1016/j.ijcard.2013.07.179. Epub 2013 Jul 30. Int J Cardiol. 2013. PMID: 23972369

2

Antithrombotic therapy in very elderly patients with atrial fibrillation: is it enough to assess thromboembolic risk?

Guo Y, Wu Q, Zhang L, Yang T, Zhu P, Gao W, Zhao Y, Gao M. Guo Y, et al. Clin Interv Aging. 2010 May 25;5:157-62. doi: 10.2147/cia.s9399. Clin Interv Aging. 2010. PMID: 20517485 Free PMC article. Review.

3

Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: a retrospective analysis versus sinus rhythm.

Guo Y, Zhang L, Wang C, Zhao Y, Chen W, Gao M, Zhu P, Yang T, Wang Y. Guo Y, et al. Clin Interv Aging. 2011;6:193-8. doi: 10.2147/CIA.S21775. Epub 2011 Jul 7. Clin Interv Aging. 2011. PMID: 21822374 Free PMC article.

4

Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?

Guo Y, Pisters R, Apostolakis S, Blann AD, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY. Guo Y, et al. Int J Cardiol. 2013 Sep 20;168(1):515-22. doi: 10.1016/j.ijcard.2012.09.187. Epub 2012 Oct 23. Int J Cardiol. 2013. PMID: 23103146

5

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.

Guo Y, Apostolakis S, Blann AD, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY. Guo Y, et al. Int J Cardiol. 2013 Sep 30;168(2):904-9. doi: 10.1016/j.ijcard.2012.10.052. Epub 2012 Nov 17. Int J Cardiol. 2013. PMID: 23167998

6

Inflammation in atrial fibrillation.

Guo Y, Lip GY, Apostolakis S. Guo Y, et al. J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70. doi: 10.1016/j.jacc.2012.04.063. J Am Coll Cardiol. 2012. PMID: 23194937 Free article. Review.

7

The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.

Guo Y, Lip GY, Apostolakis S. Guo Y, et al. J Cardiovasc Transl Res. 2013 Jun;6(3):388-97. doi: 10.1007/s12265-012-9427-y. Epub 2012 Dec 4. J Cardiovasc Transl Res. 2013. PMID: 23208014 Review.

8

Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients.

Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. Apostolakis S, et al. Among authors: guo y. J Am Coll Cardiol. 2013 Jan 22;61(3):386-7. doi: 10.1016/j.jacc.2012.10.010. Epub 2012 Dec 12. J Am Coll Cardiol. 2013. PMID: 23246385 Free article. No abstract available.

9

Reply: To PMID 22858389.

Apostolakis S, Lane DA, Guo Y, Buller H, Lip GYH. Apostolakis S, et al. Among authors: guo y. J Am Coll Cardiol. 2013 Jan 29;61(4):482-483. doi: 10.1016/j.jacc.2012.10.033. J Am Coll Cardiol. 2013. PMID: 23347785 Free article. No abstract available.

10

Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation.

Guo Y, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY. Guo Y, et al. Int J Cardiol. 2013 Sep 30;168(2):1502-8. doi: 10.1016/j.ijcard.2012.12.099. Epub 2013 Jan 30. Int J Cardiol. 2013. PMID: 23375056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,972 results

Search Page

Filters